With half a million people in the UK living with Alzheimer’s, the Masonic Samaritan Fund and The Freemasons’ Grand Charity have been united in their desire to support groundbreaking research that will help identify new targets for treating the disease, with a staggering donation of £175,000 to Alzheimer’s Research UK.
The expert research team, led by Prof Clemens Kaminski at the University of Cambridge, want to understand the chain of events that occur right at the beginning of the onset of the disease. The scientists hope the knowledge gained from this vital research will offer new clues for treatment.
Freemasons from the Provincial Grand Lodge of Cambridgeshire presented the generous donation at a cheque presentation in Professor Kaminski’s laboratory.
Ian Wilson, Director of Fundraising at Alzheimer’s Research UK who accepted the £175,000 donation said: “We are delighted that The Freemasons’ Grand Charity and the Masonic Samaritan Fund have chosen to support Alzheimer’s Research UK’s fight to defeat dementia.
“Research holds the answers to find ways to prevent, diagnose and treat Alzheimer’s and other forms of dementia, but it is massively underfunded. This huge contribution will fund two years of pioneering research at the University of Cambridge. As an independent charity, Alzheimer’s Research UK is completely reliant on the generosity of donors and this marvellous donation will take us all closer to a world free of dementia.”
Alzheimer’s disease, which affects memory and thinking, is characterised by the build-up of two toxic proteins – amyloid and tau. These protein clumps cause damage to nerve cells and lead to the symptoms experienced by those living with Alzheimer’s. But it is still not fully understood how these clumps of protein inflict damage on nerve cells. This generous support from the two Masonic charities will help Dr Kaminski and his team quite literally shine a light on the initial stages of Alzheimer’s.
Peter Sutton, Provincial Information Officer for Cambridgeshire Freemasons, said: “We are delighted to support Alzheimer’s Research UK in its mission to undertake pioneering research that brings us closer to a treatment for this cruel disease.
“Alzheimer’s is a disease that touches so many of us, family, friends and colleagues. All Cambridgeshire Freemasons look forward to following the progress of Professor Kaminski and his team as they strive to understand the fundamental basics underlying Alzheimer’s disease. Freemasons throughout the country are proud to be part of the fight against dementia.”